Viking Therapeutics, Inc. (VKTX)
32.15
-0.40
(-1.23%)
USD |
NASDAQ |
Mar 24, 16:00
32.11
-0.04
(-0.12%)
After-Hours: 20:00
Viking Therapeutics Total Liabilities (Quarterly) : 76.67M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 85.94B |
| Amgen, Inc. | 81.93B |
| Pfizer Inc. | 121.38B |
| Hims & Hers Health, Inc. | 1.614B |
| Altimmune, Inc. | 55.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 715.73M |
| Shareholders Equity (Quarterly) | 639.06M |
| Debt to Equity Ratio | 0.0002 |
| Current Ratio | 9.334 |
| Net Debt Paydown Yield | 0.01% |